Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-20-255111
Filing Date
2020-09-28
Accepted
2020-09-28 06:11:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d74674d8a12b.htm 8-A12B 12823
  Complete submission text file 0001193125-20-255111.txt   13792
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 (202) 421-7994
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-39567 | Film No.: 201201931
SIC: 2836 Biological Products, (No Diagnostic Substances)